StockData
Genprex, Inc. logo

Genprex, Inc. (GNPX) stock

GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.67−0.23 (-12.08%)

Close on Nov 17, 2026Market cap $1.37MP/E –Yield –

Genprex market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Genprex's market cap was $1.16M on Nov 11, 2026, against $65.40M a year earlier. Over the last 5 years it ranged from $1.13M to $2.40B, with a median of $131.64M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.16M-97.0%
2025Dec 31, 2025$38.67M-62.4%
2024Dec 31, 2024$102.85M-65.8%
2023Dec 29, 2023$300.75M-80.4%
2022Dec 30, 2022$1.53B+11.2%
2021Dec 31, 2021$1.38B-61.8%
2020Dec 31, 2020$3.60B+3130.6%
2019Dec 31, 2019$111.54M-69.4%
2018Dec 31, 2018$364.78M–

More Genprex figures

See a number that looks wrong?